LifeVantage Co. (NASDAQ:LFVN) Shares Sold by Empowered Funds LLC

Empowered Funds LLC lessened its position in shares of LifeVantage Co. (NASDAQ:LFVN - Free Report) by 38.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 48,860 shares of the company's stock after selling 29,999 shares during the period. Empowered Funds LLC owned approximately 0.39% of LifeVantage worth $857,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in LFVN. Copeland Capital Management LLC purchased a new stake in shares of LifeVantage in the fourth quarter worth about $65,000. Barclays PLC boosted its position in shares of LifeVantage by 38.2% in the third quarter. Barclays PLC now owns 41,966 shares of the company's stock worth $507,000 after buying an additional 11,608 shares during the period. HighTower Advisors LLC purchased a new stake in shares of LifeVantage in the third quarter worth about $638,000. Ritholtz Wealth Management boosted its position in shares of LifeVantage by 65.2% in the fourth quarter. Ritholtz Wealth Management now owns 47,348 shares of the company's stock worth $830,000 after buying an additional 18,682 shares during the period. Finally, Capital Management Corp VA purchased a new stake in shares of LifeVantage in the third quarter worth about $5,073,000. Hedge funds and other institutional investors own 35.32% of the company's stock.

LifeVantage Stock Performance

Shares of NASDAQ:LFVN traded down $0.09 during trading on Friday, hitting $16.69. The company's stock had a trading volume of 258,040 shares, compared to its average volume of 313,739. LifeVantage Co. has a fifty-two week low of $5.22 and a fifty-two week high of $27.38. The stock's 50-day moving average price is $20.05 and its two-hundred day moving average price is $14.48. The company has a market capitalization of $209.46 million, a PE ratio of 29.80 and a beta of 0.84.

LifeVantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.08. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be paid a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a yield of 0.96%. The ex-dividend date of this dividend is Monday, March 3rd. LifeVantage's payout ratio is currently 28.57%.

Analyst Ratings Changes

Several research analysts recently commented on LFVN shares. Lake Street Capital started coverage on LifeVantage in a research note on Thursday, December 19th. They issued a "buy" rating and a $26.00 price target on the stock. Craig Hallum started coverage on LifeVantage in a research note on Tuesday, January 14th. They issued a "buy" rating and a $35.00 price target on the stock.

Insider Buying and Selling at LifeVantage

In other news, Director Raymond B. Greer sold 8,000 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $20.15, for a total transaction of $161,200.00. Following the sale, the director now directly owns 99,288 shares in the company, valued at approximately $2,000,653.20. This represents a 7.46 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 20.65% of the stock is currently owned by insiders.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.